Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
"some of the patiens". I would have loved to read "most of the patients", but then again, let's hope this "some" is a hefty %.
It's getting there, lol.
Wow, about 45% drop in so little time, is something up?
It's not the stock price itself that worries me, it's the fact that besides the 47M deal done by selling one physical asset, I don't see any partnership with a larger Pharma willing to pay any upfront money in order to partner any asset in the pipeline. Now, that worries me. Why would that be?
Whatever the view, IMO quite worrisome this lack of volume and of buying strength with 47M of financing.
And the fact that 0.3 did not hold.
This is a key point. I do believe and hope that they will agree to change the primary endpoint to OS.
Wolf what? How come if a stock goes down ppl talk about wolf pack? Why not financials, trial results, strategies, and so on?
Flipper, somehow as a personal opinion, I do believe they might be in talks with the FDA to change the primary endpoint to OS, and maybe they are taking time in order to have that set up. Just IMO, but it makes much sense.
Good question.
Huge good news! New financing of approx 47 $ M!
What happened to those in here speculating about a partnership deal?
Who knows, I mean, it's not the first time, as far as I do remember, that the FDA agrees to change the primary endpoint in an immunotherapy trial. It memory serves me correctly, it also happened a couple of years ago to Neostem on their trial for heart disease. Maybe the co. is in talk with the FDA to change it to OS, too? That news, if positive, would be huge.
Maybe news pending on finances...let's hope something huge hits the news within monday.
I agree, a PR monday before market opens makes very much sense to me. Moreover, in the event that some parties were potentially somehow not sure to close a financing/partnering deal before this presentation, they should now be much more optimistic.
With all due respect, besides the choice of a range of very high mutliples for sales in your modeling, your decision to not discount those peak sales at the year of possible market approval (whatever you think it is) is beyond me, it is IMO just plain wrong.
It must have been a really interesting presentation.
Yes, it seems good news, let's hope for the best.
Once the data is not public anymore, I hope a PR is quickly issued in order to let anyone (even those not attending the meeting) know all of the available info. It does seem to be good news though.
I hope you realize that was 5 months ago. 5 months!
Asco 2019 is not that far away, lol.
That IMO is not a coincidence. Something is up!
Keep it up!
I believe that what anyone would want to hear, in this message board, is that the trial actually worked but, correct me if I am wrong, there's no word out about this after so many years.
Has anyone seen business news out there?
Next ASCO? Or ASCO 2020? Who knows!
Price baked in what? In the event that trial fails (and anyone obviously hopes it will not fail), IMO the stock price will dive to 0.05$.
Wow, you listed a number of things that got me extremely worried. IMO, even if only a couple will turn up to be right, I will consider sell asap.
You discovered this trial yesterday? Lol, good catch!
Great find, the stock rocketed after the market discovered that news, didn't it?
Don't you worry, stay tuned. Lol.
I do agree that IMO those who bought at 0.17 are profiting. There's IMO absolutely no buying pressure, which I find very negative but, at the same time, it's quite obvious because noone knows when the trial Will finally see results. In this scenario, IMO, if no business news Will hit within days, it is going to be tough on the share price.
I believe IMO that those who own stock at 0.17 are simply selling.
You make some points IMO worth reading.
August was months away from June, not weeks. To me it doesn't really add-up. Moreover, if the did data lock, why not announcing it? That alone IMO would have sent the stock price higher, probably as high as holders could have started to exercise warrants and inject cash.
While this fits with my theory that Pref A's and B's were mandatorily converted in the data lock timefrase, still doesn't reply to two importante questions:
1) Where are these business news "hopefully in the coming weeks"?
2) Why didn't they partner, sell or license Direct?